Skip to main content
. 2011 Sep 30;9:85. doi: 10.1186/1477-7525-9-85

Table 1.

Sociodemographic data of the study groups including stage, therapies, participation rate

in 2000-2001 in 2006-2007

CG BC CRC CG BC CRC
Died 2 14 25
Invited (n): 131 95 51 117 81 26
Consented (n): 120 95 51 85 62 17
Complete Data (n): 115 95 49
Censored Data 7 4 1
Women (n): 80 95 30
Age (mean): 54 57.1 62
   (SD) (14.2) (9.9) (12.2)
Marital Status:
Married (n/%) 75/65.2 59/62.1 33/67.3
Single (n/%) 13/11.3 8/8.4 6/12.2
Divorced (n/%) 15/13.0 13/13.7 5/10.2
Widowed (n/%) 8/7.0 9/9.5 4/8.2
No details available (n/%) 4/3.4 6/6.3 1/2.0
Most recent profession:
Worker (n/%) 6/5.2 12/12.6 12/24.4
Employee/civil servant (n/%) 72/62.6 45/47.4 22/44.9
Self employed (n/%) 19/16.5 8/8.4 5/10.2
House wife/husband (n/%) 12/10.4 23/24.2 10/20.4
Still in education (n/%) 3/2.6 0/0 0/0
No details available (n/%) 3/2.6 7/7.3 0/0
Pension (n/%)
Karnofsky-I. %(SD) of survivors: 96.7(7.2) 88.2(12.5)
UICC stages (n/%):
I 28/29.5 6/12
II 37/38.9 9/18
I/II 3/3.2 -
III 4/4.2 15/29
II/III - 2/4
IV 23/24.2 19/37
Grading (SD): 2.0(0.62) 2.25(0.51)
Metastasis localisation (n/%):
Bone 5/5.2 1/1.9
Liver - 8/15.7
Peritoneal - 2/3.9
Lung 2/2.1 -
Multiple 9/9.4 7/13.7
others 5/5.2 1/1.9
Duration of disease (Mean/SD): 4.7/5.6 1.7/2.3
Menopausal status at diagnosis:
Premenopausal (n/%) 38/39.6
Postmenopausal (n/%) 53/55.2
Treatment:
Operation: n/% 93/97.9 51/100
Chemotherapy: n/% 55/57.9 22/44
Radiotherapy: n/% 55/57.9 8/15.7
antihormonal therapy.: n/% 55/57.9 -
mistletoe therapy: n/% 79/83.2 38/71.7

Abbreviations: control group (CG), breast cancer (BC), colorectal cancer (CRC)